Cite

HARVARD Citation

    Li, D. et al. (2019). Evaluation and use of an anti‐cynomolgus monkey CD79b surrogate antibody–drug conjugate to enable clinical development of polatuzumab vedotin. British journal of pharmacology. pp. 3805-3818. [Online]. 
  
Back to record